Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Motzer
    Motzer
  2. Basch
    Basch
  3. Elkin
    Elkin
  4. Bach
    Bach
  5. Stein
    Stein
  6. Atkinson
    Atkinson
  7. Briggs
    Briggs
  8. Kaltenboeck
    Kaltenboeck
  9. Kung
    Kung
  10. Lipitz Snyderman
    Lipitz Snyderman

Groups

  1. Genitourinary Disease Management Team (16)
  2. Solid Tumor Oncology Division (14)
  3. Population Sciences Research Program (10)
  4. Center for Hematologic Malignancies (9)
  5. Genitourinary Oncology Service (9)
  6. Surgery (9)
  7. Breast Cancer Disease Management Team (8)
  8. Head and Neck Cancer Disease Management Team (8)
  9. Hematologic Oncology, Division of (8)
  10. Epidemiology and Biostatistics (7)
Search Within
Refine Results
  1. "Value in Health"
Formats
  1. Meeting Abstract (47)
  2. Journal Article (10)
Groups
  1. Genitourinary Disease Management Team (16)
  2. Solid Tumor Oncology Division (14)
  3. Population Sciences Research Program (10)
  4. Center for Hematologic Malignancies (9)
  5. Genitourinary Oncology Service (9)
  6. Surgery (9)

More Groups

People
  1. Robert Motzer (9)
  2. Andrea Pusic (7)
  3. Ethan Basch (7)
  4. Amie Scott (6)
  5. Elena Elkin (4)
  6. Eytan Stein (3)

More People

Years
  1. 2018 (5)
  2. 2017 (17)
  3. 2016 (3)
  4. 2015 (2)
  5. 2014 (3)
  6. 2013 (6)

More Years

Publications
  1. Value in Health (57)

Results (57)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Using the rasch model to validate and enhance the interpretation of the functional assessment of cancer therapy-kidney symptom index - Disease-related symptoms scale
    Journal Article

    Luo, X.; Cappelleri, J. C.; Cella, D.; Li, J. Z.; Charbonneau, C.; Kim, S. T.; Chen, I.; Motzer, R. J.
    Value in Health (2009)

    Fulltext@MSK | Save
  • Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO good research practices task force report
    Journal Article

    Coons, S. J.; Gwaltney, C. J.; Hays, R. D.; Lundy, J. J.; Sloan, J. A.; Revicki, D. A.; Lenderking, W. R.; Cella, D.; Basch, E.
    Value in Health (2009)

    Fulltext@MSK | Save
  • An updated geographic subpopulation analysis of health-related quality of life (HRQOL) in patients with metastatic renal cell carcinoma (MRCC) enrolled in a phase III trial of sunitinib versus interferon-alfa
    Meeting Abstract

    Cella, D.; Bushmakin, A. G.; Cappelleri, J. C.; Kim, S. T.; Motzer, R. J.; Charbonneau, C.
    Value in Health (2008)

    Fulltext@MSK | Save
  • Sunitinib vs. interferon-alpha (IFN-alpha) in first-line metastatic renal cell carcinoma (mRCC): An economic evaluation
    Meeting Abstract

    Remak, E.; Brown, R.; Negrier, S.; Motzer, R. J.; Kim, S. T.; Charbonneau, C.
    Value in Health (2007)

    Fulltext@MSK | Save
  • Health-related quality of life (HRQOL) and kidney cancer-related symptoms in patients with metastatic renal cell carcinoma (MRCC) treated with sunitinib versus interferon (IFN)-alfa in a randomised, multinational phase III trial: Results for European and US subsample analyses
    Meeting Abstract

    Cella, D.; Li, J. Z.; Bushmakin, A. G.; Cappelleri, J. C.; Kim, S. T.; Chen, F.; Charbonneau, C.; Motzer, R. J.
    Value in Health (2007)

    Fulltext@MSK | Save
  • Online reporting of toxicity symptoms by lung cancer patients during chemotherapy
    Meeting Abstract

    Basch, E.; Barz, A.; Kris, M.; Culkin, A.; Schrag, D.
    Value in Health (2006)

    Fulltext@MSK | Save
  • Cost-effectiveness of hepatic artery infusion for metastatic colorectal cancer (CALGB 9481)
    Meeting Abstract

    Weeks, J. C.; Romanus, D.; Herndon, J. E.; Schrag, D.; Mayer, R. J.; Kemeny, N.
    Value in Health (2005)

    Fulltext@MSK | Save